Literature DB >> 10605029

Rescue of defective T cell development and function in Atm-/- mice by a functional TCR alpha beta transgene.

C Chao1, E M Yang, Y Xu.   

Abstract

The Atm-/- mice recapitulate most of the defects observed in ataxia-telangiectasia (A-T) patients, including a high incidence of lymphoid tumors and immune defects characterized by defective T cell differentiation, thymus hypoplasia, and defective T-dependent immune responses. To understand the basis of the T cell developmental defects in Atm-/- mice, a functional TCR alpha beta transgene was introduced into these mutant mice. Analysis of the Atm-/-TCR alpha beta+ mice indicated that the transgenic TCR alpha beta can rescue the defective T cell differentiation and partially rescue the thymus hypoplasia in Atm-/- mice, indicating that thymocyte positive selection is normal in the Atm-/- mice. In addition, cell cycle analysis of the thymocytes derived from Atm-/-TCR alpha beta+ and control mice suggested that Atm is involved in the thymocyte expansion. Finally, evaluation of the T-dependent immune responses in Atm-/-TCR alpha beta+ mice indicated that Atm is dispensable for normal T cell function. Therefore, the defective T-dependent immune responses in Atm-/- mice must be secondary to greatly reduced T cell numbers in these mutant mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10605029     DOI: 10.4049/jimmunol.164.1.345

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Dual functions of Nbs1 in the repair of DNA breaks and proliferation ensure proper V(D)J recombination and T-cell development.

Authors:  Amal Saidi; Tangliang Li; Falk Weih; Patrick Concannon; Zhao-Qi Wang
Journal:  Mol Cell Biol       Date:  2010-10-04       Impact factor: 4.272

2.  Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression.

Authors:  Connie Chao; Deron Herr; Jerold Chun; Yang Xu
Journal:  EMBO J       Date:  2006-06-01       Impact factor: 11.598

3.  TopBP1 deficiency impairs V(D)J recombination during lymphocyte development.

Authors:  Jieun Kim; Sung Kyu Lee; Yoon Jeon; Yehyun Kim; Changjin Lee; Sung Ho Jeon; Jaegal Shim; In-Hoo Kim; Seokmann Hong; Nayoung Kim; Ho Lee; Rho Hyun Seong
Journal:  EMBO J       Date:  2014-01-17       Impact factor: 11.598

4.  Targeted disruption of NBS1 reveals its roles in mouse development and DNA repair.

Authors:  Jian Kang; Roderick T Bronson; Yang Xu
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

5.  Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.

Authors:  Anthony D D'Souza; Ian A Parish; Sharen E McKay; Susan M Kaech; Gerald S Shadel
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

6.  ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor alpha locus coding end breaks.

Authors:  Melanie S Vacchio; Alexandru Olaru; Ferenc Livak; Richard J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-03       Impact factor: 11.205

7.  Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia.

Authors:  R Schubert; J Reichenbach; S Zielen
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

8.  Defects in coding joint formation in vivo in developing ATM-deficient B and T lymphocytes.

Authors:  Ching-Yu Huang; Girdhar G Sharma; Laura M Walker; Craig H Bassing; Tej K Pandita; Barry P Sleckman
Journal:  J Exp Med       Date:  2007-05-14       Impact factor: 14.307

9.  Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice.

Authors:  P R Borghesani; F W Alt; A Bottaro; L Davidson; S Aksoy; G A Rathbun; T M Roberts; W Swat; R A Segal; Y Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia.

Authors:  Tannaz Moeini Shad; Bahman Yousefi; Parisa Amirifar; Samaneh Delavari; William Rae; Parviz Kokhaei; Hassan Abolhassani; Asghar Aghamohammadi; Reza Yazdani
Journal:  J Clin Immunol       Date:  2020-10-14       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.